A Salomon1, I Berry1, A R Tuite1, S Drews2, T Hatchette3, F Jamieson4, C Johnson5, J Kwong1, B Lina6, J Lojo5, A Mosnier7, V Ng8, P Vanhems9, D N Fisman10. 1. Dalla Lana School of Public Health, University of Toronto, Toronto, Canada. 2. Canadian Blood Services, Ottawa, Canada; University of Alberta, Edmonton, Canada. 3. Nova Scotia Health Authority, Halifax, Canada; Dalhousie University, Halifax, Canada. 4. Public Health Ontario, Toronto, Canada. 5. Philadelphia Department of Public Health, Philadelphia, Pennsylvania, USA. 6. Université de Lyon, Lyon, France; Laboratory of Virology, Centre National de Référence des Virus Influenzae, Hospices Civils de Lyon, Lyon, France. 7. Groupes Regionaux d'Observation de la Grippe, Open Rome, Paris, France. 8. Public Health Agency of Canada, Guelph, Canada. 9. Université de Lyon, Lyon, France; Unité d'Hygiène, Epidémiologie et Prévention, Groupement Hospitalier Centre, Hospices Civils de Lyon, Lyon, France. 10. Dalla Lana School of Public Health, University of Toronto, Toronto, Canada. Electronic address: david.fisman@utoronto.ca.
Abstract
OBJECTIVES: Invasive meningococcal disease (IMD) is a severe bacterial infection that displays wintertime seasonality in temperate countries. Mechanisms driving seasonality are poorly understood and may include environmental conditions and/or respiratory virus infections. We evaluated the contribution of influenza and environmental conditions to IMD risk, using standardized methodology, across multiple geographical regions. METHODS: We evaluated 3276 IMD cases occurring between January 1999 and December 2011 in 11 jurisdictions in Australia, Canada, France and the United States. Effects of environmental exposures and normalized weekly influenza activity on IMD risk were evaluated using a case-crossover design. Meta-analytic methods were used to evaluate homogeneity of effects and to identify sources of between-region heterogeneity. RESULTS: After adjustment for environmental factors, elevated influenza activity at a 2-week lag was associated with increased IMD risk (adjusted odds ratio (OR) per standard deviation increase 1.29; 95% confidence interval, 1.04-1.59). This increase was homogeneous across the jurisdictions studied. By contrast, although associations between environmental exposures and IMD were identified in individual jurisdictions, none was generalizable. CONCLUSIONS: Using a self-matched design that adjusts for both coseasonality and case characteristics, we found that surges in influenza activity result in an acute increase in population-level IMD risk. This effect is seen across diverse geographic regions in North America, France and Australia. The impact of influenza infection on downstream meningococcal risk should be considered a potential benefit of influenza immunization programmes. Crown
OBJECTIVES:Invasive meningococcal disease (IMD) is a severe bacterial infection that displays wintertime seasonality in temperate countries. Mechanisms driving seasonality are poorly understood and may include environmental conditions and/or respiratory virus infections. We evaluated the contribution of influenza and environmental conditions to IMD risk, using standardized methodology, across multiple geographical regions. METHODS: We evaluated 3276 IMD cases occurring between January 1999 and December 2011 in 11 jurisdictions in Australia, Canada, France and the United States. Effects of environmental exposures and normalized weekly influenza activity on IMD risk were evaluated using a case-crossover design. Meta-analytic methods were used to evaluate homogeneity of effects and to identify sources of between-region heterogeneity. RESULTS: After adjustment for environmental factors, elevated influenza activity at a 2-week lag was associated with increased IMD risk (adjusted odds ratio (OR) per standard deviation increase 1.29; 95% confidence interval, 1.04-1.59). This increase was homogeneous across the jurisdictions studied. By contrast, although associations between environmental exposures and IMD were identified in individual jurisdictions, none was generalizable. CONCLUSIONS: Using a self-matched design that adjusts for both coseasonality and case characteristics, we found that surges in influenza activity result in an acute increase in population-level IMD risk. This effect is seen across diverse geographic regions in North America, France and Australia. The impact of influenza infection on downstream meningococcal risk should be considered a potential benefit of influenza immunization programmes. Crown
Authors: Susan Meiring; Stefano Tempia; Emanuel M Dominic; Linda de Gouveia; Jo McAnerney; Anne von Gottberg; Cheryl Cohen Journal: Clin Infect Dis Date: 2022-05-30 Impact factor: 20.999
Authors: Mark McMillan; Jana Bednarz; Lex E X Leong; Andrew Lawrence; Helen S Marshall Journal: Pediatr Infect Dis J Date: 2022-07-27 Impact factor: 3.806
Authors: Angela B Brueggemann; Melissa J Jansen van Rensburg; David Shaw; Noel D McCarthy; Keith A Jolley; Martin C J Maiden; Mark P G van der Linden; Zahin Amin-Chowdhury; Désirée E Bennett; Ray Borrow; Maria-Cristina C Brandileone; Karen Broughton; Ruth Campbell; Bin Cao; Carlo Casanova; Eun Hwa Choi; Yiu Wai Chu; Stephen A Clark; Heike Claus; Juliana Coelho; Mary Corcoran; Simon Cottrell; Robert J Cunney; Tine Dalby; Heather Davies; Linda de Gouveia; Ala-Eddine Deghmane; Walter Demczuk; Stefanie Desmet; Richard J Drew; Mignon du Plessis; Helga Erlendsdottir; Norman K Fry; Kurt Fuursted; Steve J Gray; Birgitta Henriques-Normark; Thomas Hale; Markus Hilty; Steen Hoffmann; Hilary Humphreys; Margaret Ip; Susanne Jacobsson; Jillian Johnston; Jana Kozakova; Karl G Kristinsson; Pavla Krizova; Alicja Kuch; Shamez N Ladhani; Thiên-Trí Lâm; Vera Lebedova; Laura Lindholm; David J Litt; Irene Martin; Delphine Martiny; Wesley Mattheus; Martha McElligott; Mary Meehan; Susan Meiring; Paula Mölling; Eva Morfeldt; Julie Morgan; Robert M Mulhall; Carmen Muñoz-Almagro; David R Murdoch; Joy Murphy; Martin Musilek; Alexandre Mzabi; Amaresh Perez-Argüello; Monique Perrin; Malorie Perry; Alba Redin; Richard Roberts; Maria Roberts; Assaf Rokney; Merav Ron; Kevin J Scott; Carmen L Sheppard; Lotta Siira; Anna Skoczyńska; Monica Sloan; Hans-Christian Slotved; Andrew J Smith; Joon Young Song; Muhamed-Kheir Taha; Maija Toropainen; Dominic Tsang; Anni Vainio; Nina M van Sorge; Emmanuelle Varon; Jiri Vlach; Ulrich Vogel; Sandra Vohrnova; Anne von Gottberg; Rosemeire C Zanella; Fei Zhou Journal: Lancet Digit Health Date: 2021-06